Performance of an Idiopathic Pulmonary Fibrosis–Derived Multibiomarker Panel for Rheumatoid Arthritis–Associated Interstitial Lung Disease

A multibiomarker panel derived from IPF-associated biomarkers was associated with RA-ILD in separate development and validation cohorts. This overlap supports the concept of shared etiopathogenesis of IPF and RA-ILD and illustrates the potential for peripheral blood biomarker panels to stratify ILD risk among patients with RA.

Authors

Institutions

Publication Details

Journal
Arthritis & Rheumatology
Published
2025-09-16
DOI
https://doi.org/10.1002/art.43383
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Performance of an Idiopathic Pulmonary Fibrosis–Derived Multibiomarker Panel for Rheumatoid Arthritis–Associated Interstitial Lung Disease

Katherine D. Wysham, Dana P. Ascherman, Gail S. Kerr, Punyasha Roul et al.
Arthritis & Rheumatology
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
article

Performance of an Idiopathic Pulmonary Fibrosis–Derived Multibiomarker Panel for Rheumatoid Arthritis–Associated Interstitial Lung Disease

Katherine D. Wysham, Dana P. Ascherman, Gail S. Kerr, Punyasha Roul, Gary A. Kunkel, Scott M. Matson, Andreas Reimold, Jill A. Poole, Geoffrey M. Thiele, Daniel J. Kass, Brent A. Luedders, Paul A. Monach, Ted R. Mikuls, Bryant R. England, Yangyuna Yang, Grant W. Cannon, Michael J. Duryee, Joshua F. Baker, Halie Frideres
article en

Abstract

A multibiomarker panel derived from IPF-associated biomarkers was associated with RA-ILD in separate development and validation cohorts. This overlap supports the concept of shared etiopathogenesis of IPF and RA-ILD and illustrates the potential for peripheral blood biomarker panels to stratify ILD risk among patients with RA.

Arthritis & RheumatologyVol. 78(2)
Howard University (US), University of Kansas (US), University of Pittsburgh (US), Georgetown University (US), University of Washington (US), University of Utah (US), VA Boston Healthcare System (US), The University of Kansas Health System (US), VA Salt Lake City Healthcare System (US), VA Puget Sound Health Care System (US), VA North Texas Health Care System (US), University of Kansas Medical Center (US), Philadelphia VA Medical Center (US), Washington DC VA Medical Center (US), VA Nebraska Western Iowa Health Care System (US), Seattle University (US), University of Nebraska Medical Center (US), University of Pennsylvania (US), The University of Texas Southwestern Medical Center (US), Philadelphia University (US)
U.S. Department of Defense, U.S. Department of Veterans Affairs, Amgen, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Rheumatology Research Foundation, CSL Behring, Regeneron Pharmaceuticals, National Institutes of Health, Clinical Science Research and Development, National Institute for Occupational Safety and Health
Openalex Percentile: Top 64%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.